Skip to main content
Clinical Trials/ACTRN12617001065381
ACTRN12617001065381
Completed
Phase 3

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer (VAPOR-C): A Feasibility Study

Peter MacCallum Cancer Centre Office of Cancer Research0 sites169 target enrollmentJuly 21, 2017

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Peter MacCallum Cancer Centre Office of Cancer Research
Enrollment
169
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 21, 2017
End Date
August 21, 2020
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Peter MacCallum Cancer Centre Office of Cancer Research

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female
  • 2\. Age 18\-80 years.
  • 3\. Elective surgery
  • 4\. Major cancer surgery expecting to last two or more hours, for:
  • Breast (mastectomy or segmentectomy PLUS sentinel node dissection),
  • Colorectal,
  • Melanoma (excision of melanoma PLUS lymph node dissection AND/OR skin flap construction, or
  • Other major cancer surgeries (e.g. oesophagectomy, head and neck cancer, etc.)

Exclusion Criteria

  • 1\. Palliative surgery for end\-stage disease with no curative intent
  • 2\. Emergency surgery
  • 3\. Extensive co\-morbid disease, i.e. ASA \>4
  • 4\. Refusal or inability to provide valid informed consent
  • 5\. Risk of severe postoperative nausea and vomiting (PONV risk score \>3\)
  • 6\. Previous allergy or contraindication to either anaesthetic medication
  • 7\. Indication for gas induction of anaesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials